Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

10 juil. 2026 15h07 HE | Source: Robbins LLP

Robbins LLP Urges ERAS Stockholders to Contact the Firm for Information About the Class Action Against Erasca, Inc.

Robbins LLP Urges ERAS Stockholders to Contact the Firm for Information About the Class Action Against Erasca, Inc.
03 juil. 2026 10h00 HE | Source: Robbins LLP

EMBC Stockholders Have Rights – If You Lost Money Investing in Embecta Corp. Contact Robbins LLP for Information About Recovering Your Losses

Robbins LLP is Investigating Allegations that Embecta Corp. (EMBC) Misled Investors Regarding its Business Prospects
01 juil. 2026 18h21 HE | Source: Robbins LLP

GRAL Investors Have Rights – If You Lost Money Investing in Grail, Inc. Contact Robbins LLP for Information About Recovering Your Losses

Robbins LLP is Investigating Allegations that Grail, Inc. (GRAL) Misled Investors Concerning the Success of its NHS-Galleri Trial
05 juin 2026 13h57 HE | Source: Robbins LLP

Robbins LLP Reminds IMMP Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action Against Immutep Limited

Robbins LLP is Investigating Allegations that Immutep Limited (IMMP) Misled Investors Regarding the Viability and Efficacy of its Drug Candidate
01 juin 2026 13h37 HE | Source: Robbins LLP

ZTS Class Action Reminder - Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Zoetis Inc. Class Acton Lawsuit

Robbins LLP is Investigating Allegations that Zeotis Inc. (ZTS) Misled Investors Regarding its Flagship Products as a Durable Growth Engine
06 mai 2026 15h12 HE | Source: Robbins LLP

Medpace Holdings Inc. Class Action Lawsuit – Robbins LLP Reminds MEDP Investors of the Upcoming Lead Plaintiff Deadline; Contact Us Today for Information About Recovering Your Losses

Robbins LLP is Investigating Allegations that Medpace Holdings Inc. (MEDP) Misled Investors Regarding its Expected Book-to-Bill Ratio
14 avr. 2026 17h27 HE | Source: Robbins LLP

Did You Lose Money Investing in Medpace Holdings Inc.? Robbins LLP Urges Investors with Significant Losses to Contact the Firm for Information About Their Rights Against MEDP

Robbins LLP is Investigating Allegations that Medpace Holdings Inc. (MEDP) Misled Investors Regarding its Expected Book-to-Bill Ratio
26 mars 2026 17h28 HE | Source: Robbins LLP

ATRA Class Action Reminder - Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Atara Biotherapeutics, Inc. Class Action

Robbins LLP is Investigating Allegations that Atara Biotherapeutics, Inc. (ATRA) Misled Investors Regarding its Drug Candidate
05 mars 2026 14h21 HE | Source: Robbins LLP

POM Class Action: POMDoctor Ltd. Stockholders with Large Losses Should Contact Robbins LLP for Information About Recovering Their Losses

Robbins LLP is Investigating Allegations that POMDoctor Ltd. (POM) was the Subject of a Pump-and-Dump Scheme
04 mars 2026 13h40 HE | Source: Robbins LLP

Robbins LLP Urges MREO Stockholders to Contact the Firm for Information About the Class Action Against Mereo BioPharma Group plc

Robbins LLP is Investigating Allegations that Mereo BioPharma Group plc (MREO) Misled Investors Regarding Phase 3 Orbit and Cosmic Studies for Setrusumab

Page suivante